-
6 Reasons Why William Blair Turned Bullish On Abbot Laboratories
Thursday, January 25, 2018 - 4:52pm | 426Read More...Abbott Laboratories (NYSE: ABT) reported fourth-quarter results that were highlighted by a top- and bottom-line beat and a guidance range for the first quarter that came in ahead of the consensus estimate. The Analyst William Blair's Margaret Kaczor upgraded Abbott Laboratories...
-
Time To Buy EndoChoice, William Blair Says
Tuesday, June 30, 2015 - 8:10am | 228Read More...In a report published Tuesday, William Blair analyst Margaret Kaczor initiated coverage of EndoChoice Holdings Inc (NYSE: GI) with an Outperform rating. According to the William Blair report, "EndoChoice is the only company to address the continuum of care in the $6 billion worldwide...
-
UPDATE: William Blair & Company Initiates Coverage on Zoetis on Good Earnings Growth Potential
Monday, November 25, 2013 - 12:01pm | 167Read More...In a report published Monday, William Blair & Company analyst Margaret Kaczor initiated coverage on Zoetis (NYSE: ZTS) with a Market Perform rating. In the report, William Blair & Company noted, “We are initiating coverage of ZTS with a Market Perform rating and Established Growth company...
